Kim A. Heidenreich, PhD - Neuropharmacology


Manager and Co-Founder of BP
Invention, scientific platform, IP, regulatory pathway, clinical trial program initiatives
Professor Emeritus of Pharmacology and Neuroscience at University of Colorado School of Medicine; Research Career Scientist, Denver VA Medical Center

Research: neurotrophic factors, neuronal cell death mechanisms, and role of neuroinflammation in neurodegenerative diseases—NIH and VA grant funding for 30 years; 93 peer-reviewed publications in highly-respected journals: 30 graduate student and postdoctoral fellow trainees; Elected member (3 terms) of Keystone Scientific Advisory Board, Neurobiology section; established TBI as topic at Keystone Meetings
Awards: Dean's Mentoring Award-UC Denver Graduate School; Neuroscience Translational Research Award-UC School of Medicine; Endowment from the Rose Foundation-affiliate UC School of Medicine
Media: interviewed by CBC (News 4), Forbes magazine, Science, and W3W3 radio; Invited speaker at numerous national and International meetings including the 2013 and 2014 C4CT Concussion Awareness Summits